Corbus Pharmaceuticals
CRBP
CRBP
103 hedge funds and large institutions have $155M invested in Corbus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $224M → $155M (-$69.4M)
40% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 35
44% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $2.13M
Holders
103
Holding in Top 10
1
Calls
$1.19M
Puts
$2.13M
Top Buyers
| 1 | +$1.06M | |
| 2 | +$647K | |
| 3 | +$395K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$382K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$298K |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$1.03M | |
| 3 | -$903K | |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$593K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$405K |